drugset / Trial / NCT03663686
The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female Subjects
RandomizedSequentialQuadruple-blindTreatment
Summary
The Safety, Tolerability and Pharmacokinetic Study of Asthma Treatment Drug Litapiprant Tablets in Healthy Male and Female subjects.
Timeline
- Start
- 2018-10-25
- Primary completion
- 2019-01-30
- Completion
- 2019-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Litapiprant | Small molecule | 25 mg | Oral |
| Comparator | Litapiprant | Small molecule | 50 mg | Oral |
| Comparator | Litapiprant | Small molecule | 100 mg | Oral |
| Comparator | Litapiprant | Small molecule | 200 mg | Oral |
| Comparator | Litapiprant | Small molecule | 400 mg | Oral |
| Comparator | Litapiprant | Small molecule | 600 mg | Oral |
| Comparator | Litapiprant | Small molecule | 800 mg | Oral |